anonymous
Guest
anonymous
Guest
2016, come and gone.....but what is still here, MET! C'mon Haters, predict our demise for 2017. Guess wrong again in 17!!!
Thats right baby. We are the proof of how well run this company truly is. Putting Humira and HCV reps on notice for looking at them sideways but keeping that vast growth machine called Metabolics.
Hey, I love it. I gave up on getting a fat severence to leave here and enjoy my well padded retirement. I will continue to fake my Met calls and collect 100% of my pay while my 401K continues to climb. I still have almost the same amount of free time as if I retired anyway but with bennies and more cashola!!
Cant beat that with a stick. Worse case, if they ever wake up, I will take my bundle and gladly ride offf into the sunset.
My only concern is that Trump sounds very serious about forcing Pharma to negotiate drug prices and wants to use reimport from Canada or Mexico as a source of cheaper drugs if we don't start drastically dropping our prices.
First president ever who will most likely do just that and put our profitiable nuts in a very tight vice. Good news it will take until at least midyear for the bosses to make adjustments in headcount to account for this grilling. Thats six more months of paid vacation!!